Brief: Biotalys H1 Operating Loss Widens To 9.7 Million Euros

Biotalys NV

19/08/2022 06:18

Aug 19 (Reuters) - Biotalys NV  BTLS.BR :
    * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 45.6 MILLION END
OF
JUNE 2022
    * H1 OPERATING LOSS EUR 9.7 MILLION VERSUS LOSS EUR 8.4
MILLION
YEAR AGO
    * H1 LOSS FOR THE PERIOD EUR 9.9 MILLION VERSUS LOSS EUR 7.2
MILLION YEAR AGO
    * OUTCOME OF ONGOING FEASIBILITY STUDY WITH NOVOZYMES IS
EXPECTED
IN EARLY 2023
    * HAS REDUCED EXPECTED CASH BURN FOR FULL YEAR 2022 TO A
RANGE
BETWEEN EUR 24 AND EUR 26 MLN
    * BIOTALYS EXPECTS TO OBTAIN FIRST REGISTRATION FOR EVOCA IN
UNITED STATES
    * EXPECTS TO OBTAIN EVOCA REGISTRATION FROM US EPA IN EARLY
2023

Source text for Eikon:  ID:nGNE3DSxpM 
Further company coverage:  BTLS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))